Connect with us

Technologies

FDA committee endorses COVID vaccine for kids ages 5-11: Here’s the latest

If authorized and recommended, shots could be given out to young kids as early as next week. Here’s what to know before your child becomes eligible.

For the most up-to-date news and information about the coronavirus pandemic, visit the WHO and CDC websites.

A panel of independent advisers to the US Food and Drug Administration voted Tuesday to recommended Pfizer’s COVID-19 vaccine to kids ages 5 to 11. The FDA still needs to give the vaccine official authorization, and another independent committee to the US Centers for Disease Control and Prevention will issue guidance next week on how shots roll out, but the vaccine could be available to younger kids soon after that.

Last week, the White House shared a plan to get kids under 12 vaccinated against the coronavirus, saying it «will be ready to begin getting shots in arms in the days following a final CDC recommendation.» In addition to Pfizer’s vaccine being a lower dose for kids ages 5 to 11 (one-third the dose given to everyone else), we may expect the COVID-19 campaign to look different for those in that age group.

Children remain at low risk of severe COVID-19 disease and death compared with the adult population (of states that reported data to the American Academy of Pediatrics, 0.1% to 2% of COVID-19 cases in children resulted in hospitalization). But children can experience complications from COVID-19, including long COVID. According to a poll by the Kaiser Family Foundation, about one-third of parents said they would vaccinate their child age 5 to 11 «right away» after they become eligible for a COVID-19 vaccine.

Although kids age 11 or younger can’t be vaccinated quite yet, teens ages 12 and up can be. While we wait for final recommendations for younger kids, here’s what we know about COVID-19 vaccines for kids.

When will kids be able to get a COVID-19 vaccine?

Kids ages 12 and up are able to get Pfizer’s COVID-19 vaccine. The other mRNA vaccine, Moderna, and the only single-dose vaccine on the US market, Johnson & Johnson, aren’t available for kids yet.

The FDA’s advisory committee met Tuesday and voted on recommending Pfizer’s COVID-19 vaccine for kids ages 5 to 11. Pfizer said in September that its vaccine is safe and effective for children in that age group, and members of the FDA’s committee ultimately voted that the benefits of vaccinating younger kids outweighed the risks. If an authorization is formally accepted by the FDA, an independent advisory committee to the US Centers for Disease Control and Prevention will meet Nov. 2-3 to decide how the shots will be administered to children, and the CDC will need to formally accept its recommendation. Both agencies typically follow the advice of their advisory committees, so we can expect a final decision for kids ages 5 to 11 next week.

Do I need to give consent in order for my young child to get vaccinated?

Yes, parents generally need to consent to their children receiving medical care, which will include Pfizer’s COVID-19 vaccine. This is especially true for younger children.

However, if you have a teenager or child old enough to express a desire to get a COVID-19 vaccine, but their desire is different than yours, they may have legal precedent to seek one out, depending on which state you live in.

In Tennessee, the rights of minors versus their parents when it comes to vaccine decisions came under the spotlight last summer when the state’s vaccine director, Michelle Fiscus, was allegedly fired, in part, for sending out a memo explaining Tennessee’s «mature minor doctrine,» which is the state’s writing on how minors may seek medical care without the consent of their parents in some cases.

If my child is immunocompromised or has a health condition, can they get a booster?

If your child is at least 12 years old, «moderately or severely» immunocompromised and vaccinated with Pfizer, according to the CDC, they should get a third dose of Pfizer. Moderna is only authorized for people aged 18 and older. Examples of people who are immunocompromised include people receiving treatment for cancers in the blood or tumors, organ transplant recipients, stem cell transplant recipients, people with untreated or advanced HIV infection and people taking drugs that could suppress the immune response, per the CDC.

The boosters currently available to some Americans who received Moderna, Pfizer or Johnson & Johnson only applies to adults age 18 or older. No minor is eligible for a booster.

Does Pfizer’s full FDA approval extend to kids?

The FDA’s approval of the vaccine by Pfizer and its partner, BioNTech, only applies to people as young as 16 years old. While Pfizer remains the only vaccine authorized for use in kids as young as 12 years old, vaccinating that age group is still under emergency use authorization rather than total approval. This is because, along with other factors, full FDA approval requires data on how the vaccine fares six months out, per NPR. Pfizer’s vaccine was only authorized for kids aged 12 to 15 in May.

This means that a vaccine mandate that hinges on full approval of a coronavirus vaccine, such as the one announced for schoolkids in California, won’t apply to kids younger than 16 for a while.

My child has allergies. Can they get the vaccine?

«If the child has a history of anaphylaxis or other severe allergies, then the observation time after the injection may be 30 minutes instead of 15,» Dr. Anne Liu, an infectious disease specialist with Stanford Hospital and Clinics and the Lucile Packard Children’s Hospital, said in August. So you might be asked to stick around the waiting room with your child for an extra 15 minutes so health care providers can monitor vaccine recipients for the (extremely rare) allergic reaction that can occur after any vaccination.

Additionally, Liu said, children who are prescribed an EpiPen for any reason should bring it to their vaccine appointment.

If your child has a severe allergy to any of the ingredients in the vaccine available to them, they shouldn’t take it, according to the World Health Organization. Adults allergic to any ingredient a COVID-19 also shouldn’t take that vaccine. Find the ingredients for Pfizer on the FDA fact sheet, as well as Moderna’s components.

Can my child get the COVID-19 shot at the same time as other vaccines?

Yes, according to the CDC, your child may get other vaccines when they go in for their coronavirus shot without waiting 14 days between appointments.

Should I worry about myocarditis?

Myocarditis and pericarditis, or inflammation in the heart, is a rare side effect linked to Moderna and Pfizer vaccines, mostly in adolescent males and young adults. After looking at data and weighing the risks and benefits, the CDC still recommends everyone, including children as young as 12, get vaccinated. According to a Washington Post report, the CDC and FDA are looking into Canadian data that suggests Moderna might carry a higher risk of myocarditis than Pfizer, mainly in young people.

When cases of myocarditis have occurred, Liu said, the cases have typically responded to treatment and resolved themselves, even when patients were hospitalized for a day or two.

«COVID-19 infection can have much more serious consequences for the heart than the vaccine,» Liu said.

The government in Singapore, where 82% of the population is fully vaccinated, recommends that people, especially adolescents and young men, refrain from strenuous exercise for a week after their second dose of a COVID-19 vaccine. The CDC recommends speaking to a doctor about when to return to sports or exercise following a diagnosis of myocarditis.

If I’m pregnant or breastfeeding, can I get vaccinated?

Yes, according to the CDC, because pregnant people are at much higher risk of severe COVID-19 and complications, including death, than people who aren’t pregnant.

Preliminary data shared by the CDC showed there was no increased risk of miscarriage among those who got an mRNA vaccine before the 20th week of pregnancy compared with those who didn’t.

My child can’t be vaccinated yet. What should we do?

When spending time with other families with children, it’s best if everyone continues to wear a mask, according to Harvard Health, and they should isolate themselves if there’s a COVID-19 exposure. Additionally, choosing more outdoor activities and avoiding crowds, even when outdoors, can help protect your kids. Parents and older siblings who are vaccinated should also mask up to prevent breakthrough infections that can spread to vulnerable people who aren’t as protected, including kids.

The CDC has prioritized in-person learning for students this fall, and it has guidance on prevention strategies schools should use to keep students and staff safe.

Correction, Oct. 25: A previous version of this story included a sentence implying incorrect information about available vaccines for children age 12 and older. Only Pfizer’s vaccine is currently available to kids ages 12 to 17.

The information contained in this article is for educational and informational purposes only and is not intended as health or medical advice. Always consult a physician or other qualified health provider regarding any questions you may have about a medical condition or health objectives.

Technologies

Google races to put Gemini at the center of Android before Apple’s AI reboot

Google is using its latest Android rollout to position Gemini as the AI layer across phones, Chrome, laptops and cars.

Google is using its latest Android rollout to make Gemini less of a chatbot and more of an operating layer across the phone, browser, car and laptop, just weeks before Apple is expected to show its own Gemini-powered Apple Intelligence reboot at WWDC.
Ahead of its Google I/O developer conference next week, the company previewed a number of Android updates, including AI-powered app automation, a smarter version of Chrome on Android, new tools for creators, a redesigned Android Auto experience, and a sweeping set of new security features.
Alphabet is counting on Gemini to help Google compete directly with OpenAI and Anthropic in the market for artificial intelligence models and services, while also serving as the AI backbone across its expansive portfolio of products, including Android. Meanwhile, Gemini is powering part of Apple’s new AI strategy, giving Google a role in the iPhone maker’s reset even as it races to prove its own version of personal AI on the phone is further along.
Sameer Samat, who oversees Google’s Android ecosystem, told CNBC that Google is rebuilding parts of Android around Gemini Intelligence to help users complete everyday tasks more easily.
“We’re transitioning from an operating system to an intelligence system,” he said.
As part of Tuesday’s announcements. Google said Gemini Intelligence will be able to move across apps, understand what’s on the screen and complete tasks that would normally require a user to jump between multiple services. That means Android is moving beyond the traditional assistant model, where users ask a question and get an answer, and acting more like an agent.
For instance, Google says Gemini can pull relevant information from Gmail, build shopping carts and book reservations. Samat gave the example of asking Gemini to look at the guest list for a barbecue, build a menu, add ingredients to an Instacart list and return for approval before checkout.
A big concern surrounding agentic AI involves software taking action on a user’s behalf without permissions. Samat said Gemini will come back to the user before completing a transaction, adding, “the human is always in the loop.”
Four months after announcing its Gemini deal with Google, Apple is under pressure to show a more capable version of Apple Intelligence, which has been a relative laggard on the market. Apple has long framed privacy, hardware integration and control of the user experience as its advantages.
Google’s Android push is designed to show it can bring AI deeper into the device experience while still giving users control over what Gemini can see, where it can act and when it needs confirmation.
The app automation features will roll out in waves, starting with the latest Samsung Galaxy and Google Pixel phones this summer, before expanding across more Android devices, including watches, cars, glasses and laptops later this year.
The company is also redesigning Android Auto around Gemini, turning the car into another major surface for its assistant. Android Auto is in more than 250 million cars, and Google says the new release includes its biggest maps update in a decade and Gemini-powered help with tasks like ordering dinner while driving.
Alphabet’s AI strategy has been embraced by Wall Street, which has pushed the company’s stock price up more than 140% in the past year, compared to Apple’s roughly 40% gain. Investors now want to see how Gemini can become more central to the products people use every day.
WATCH: Alphabet briefly tops Nvidia after report of $200 billion Anthropic cloud deal

Continue Reading

Technologies

Waymo recalls 3,800 robotaxis after glitch allowed some vehicles to ‘drive into standing water’

Waymo issued a voluntary recall of about 3,800 of its robotaxis to fix software issues that could allow them to drive into flooded roadways.

Waymo is recalling about 3,800 robotaxis in the U.S. to fix software issues that could allow them to “drive onto a flooded roadway,” according to a letter on the National Highway Traffic Safety Administration’s website.
The voluntary recall is for Waymo vehicles that use the company’s fifth and sixth generation automated driving systems (or ADS), the U.S. auto safety regulator said in the letter posted Tuesday.
Waymo autonomous vehicles in Austin, Texas, were seen on camera driving onto a flooded street and stalling, requiring other drivers to navigate around them. It’s the latest example of a safety-related issue for the Alphabet-owned AV unit that’s rapidly bolstering its fleet of vehicles and entering new U.S. markets.
Waymo has drawn criticism for its vehicles failing to yield to school buses in Austin, and for the performance of its vehicles during widespread power outages in San Francisco in December, when robotaxis halted in traffic, causing gridlock.
The company said in a statement on Tuesday that it’s “identified an area of improvement regarding untraversable flooded lanes specific to higher-speed roadways,” and opted to file a “voluntary software recall” with the NHTSA.
“Waymo provides over half a million trips every week in some of the most challenging driving environments across the U.S., and safety is our primary priority,” the company said.
Waymo added that it’s working on “additional software safeguards” and has put “mitigations” in place, limiting where its robotaxis operate during extreme weather, so that they avoid “areas where flash flooding might occur” in periods of intense rain.
WATCH: Waymo launches new autonomous system in Chinese-made vehicle

Continue Reading

Technologies

Qualcomm tumbles 13% as semiconductor stocks retreat from historic AI-fueled surge

Semiconductor equities reversed sharply after a broad AI-driven advance, with Qualcomm suffering its worst day since 2020 amid inflation concerns and rising oil prices.

Semiconductor stocks fell sharply on Tuesday, reversing course after an extensive rally that had expanded the artificial intelligence investment theme well past Nvidia and driven the industry to unprecedented levels.

Qualcomm plunged 13% and was on track for its steepest single-day decline since 2020. Intel shed 8%, while On Semiconductor and Skyworks Solutions each lost more than 6%. The iShares Semiconductor ETF, which benchmarks the overall sector, fell 5%.

The sell-off came after a key gauge of consumer prices came in above forecasts, and as conflict in Iran pushed crude oil higher—prompting investors to shift away from riskier assets.

The preceding advance had widened the AI opportunity set beyond longtime industry leader Nvidia, which for much of the past several years had largely carried the market to new peaks on its own.

Explosive appetite for central processing units, along with the graphics processing units that power large language models, has sent chipmakers to all-time highs.

Market participants are wagering that the shift from AI model training to autonomous agents will lift demand for additional AI hardware. Among the beneficiaries are memory chip producers, which are raising prices as supply remains tight.

Micron Technology slid 6%, and Sandisk cratered 8%. Sandisk’s stock has surged more than six times over since January.

Continue Reading

Trending

Copyright © Verum World Media